Zgadzay Y, Mirabello C, Wanes G, Panek T, Chauhan P, Nystedt B
bioRxiv. 2025; .
PMID: 39896671
PMC: 11785013.
DOI: 10.1101/2024.12.18.629302.
Li X, Wu Y, Zhang M, Wang F, Yin H, Zhang Y
Clin Transl Med. 2025; 15(1):e70162.
PMID: 39748215
PMC: 11695203.
DOI: 10.1002/ctm2.70162.
Xiong W, Xu K, Sun J, Liu S, Zhao B, Shi J
EMBO J. 2024; 43(23):6001-6031.
PMID: 39424953
PMC: 11612450.
DOI: 10.1038/s44318-024-00270-7.
Gutierrez-Aguilar M, Klutho P, Aguayo-Ortiz R, Song L, Baines C
J Mol Cell Cardiol. 2024; 196:1-11.
PMID: 39209214
PMC: 11534557.
DOI: 10.1016/j.yjmcc.2024.08.005.
Lin J, Hwang S, Luo H, Mohamud Y
Biology (Basel). 2024; 13(6).
PMID: 38927311
PMC: 11200454.
DOI: 10.3390/biology13060431.
Mitochondrial translation failure represses cholesterol gene expression via Pyk2-Gsk3β-Srebp2 axis.
Toshima T, Yagi M, Do Y, Hirai H, Kunisaki Y, Kang D
Life Sci Alliance. 2024; 7(7).
PMID: 38719751
PMC: 11079605.
DOI: 10.26508/lsa.202302423.
The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer.
Ghebrehiwet B, Zaniewski M, Fernandez A, DiGiovanni M, Reyes T, Ji P
Front Immunol. 2024; 15:1351656.
PMID: 38711524
PMC: 11070495.
DOI: 10.3389/fimmu.2024.1351656.
Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez C, Moreno-Londono A, Alvarado-Ortiz E, Ramos-Godinez M, Sarabia-Sanchez M, Castaneda-Patlan M
Int J Mol Sci. 2024; 25(5).
PMID: 38473963
PMC: 10931692.
DOI: 10.3390/ijms25052712.
Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
Tio M, Wen R, Choo C, Tan J, Chua A, Xiao B
J Biomed Sci. 2024; 31(1):24.
PMID: 38395904
PMC: 10893700.
DOI: 10.1186/s12929-024-01010-z.
TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors.
Alsalloum A, Alrhmoun S, Shevchenko J, Fisher M, Philippova J, Perik-Zavodskii R
Biomedicines. 2023; 11(10).
PMID: 37893178
PMC: 10604587.
DOI: 10.3390/biomedicines11102805.
Role of gC1qR as a modulator of endothelial cell permeability and contributor to post-stroke inflammation and edema formation.
Delgardo M, Tang A, Tudor T, Pascual-Leone A, Connolly Jr E
Front Cell Neurosci. 2023; 17:1123365.
PMID: 37383840
PMC: 10294424.
DOI: 10.3389/fncel.2023.1123365.
A potential histone-chaperone activity for the MIER1 histone deacetylase complex.
Wang S, Fairall L, Pham T, Ragan T, Vashi D, Collins M
Nucleic Acids Res. 2023; 51(12):6006-6019.
PMID: 37099381
PMC: 10325919.
DOI: 10.1093/nar/gkad294.
Complement component C1q initiates extrinsic coagulation via the receptor for the globular head of C1q in adventitial fibroblasts and vascular smooth muscle cells.
Freda C, Yin W, Ghebrehiwet B, Rubenstein D
Immun Inflamm Dis. 2023; 11(1):e769.
PMID: 36705413
PMC: 9868878.
DOI: 10.1002/iid3.769.
The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation.
Li C, Mori L, Lyu S, Bronson R, Getzler A, Pipkin M
Proc Natl Acad Sci U S A. 2022; 120(1):e2217476120.
PMID: 36584296
PMC: 9910500.
DOI: 10.1073/pnas.2217476120.
Toxoplasma gondii virulence factor ROP1 reduces parasite susceptibility to murine and human innate immune restriction.
Butterworth S, Torelli F, Lockyer E, Wagener J, Song O, Broncel M
PLoS Pathog. 2022; 18(12):e1011021.
PMID: 36476844
PMC: 9762571.
DOI: 10.1371/journal.ppat.1011021.
gC1qR interacts with WSSV VP28 exhibiting antiviral activity.
Wang Y, Zhang B, Zhao S, Wang Y, Chu X, Li X
Fish Shellfish Immunol Rep. 2022; 3:100052.
PMID: 36419614
PMC: 9680082.
DOI: 10.1016/j.fsirep.2022.100052.
An Epigenetic Role of Mitochondria in Cancer.
Liu Y, Chen C, Wang X, Sun Y, Zhang J, Chen J
Cells. 2022; 11(16).
PMID: 36010594
PMC: 9406960.
DOI: 10.3390/cells11162518.
gC1qR/C1qBP/HABP-1: Structural Analysis of the Trimeric Core Region, Interactions With a Novel Panel of Monoclonal Antibodies, and Their Influence on Binding to FXII.
Zhang Y, Vontz A, Kallenberger E, Xu X, Ploscariu N, Ramyar K
Front Immunol. 2022; 13:887742.
PMID: 35865516
PMC: 9294231.
DOI: 10.3389/fimmu.2022.887742.
Serum bridging molecules drive candidal invasion of human but not mouse endothelial cells.
Phan Q, Solis N, Lin J, Swidergall M, Singh S, Liu H
PLoS Pathog. 2022; 18(7):e1010681.
PMID: 35797411
PMC: 9295963.
DOI: 10.1371/journal.ppat.1010681.
The Mitochondrial Protein C1QBP Promotes Hepatocellular Carcinoma Progression by Enhancing Cell Survival, Migration and Invasion.
Hou G, Lu Z, Wang Z, Yang X
J Cancer. 2022; 13(8):2477-2489.
PMID: 35711850
PMC: 9174857.
DOI: 10.7150/jca.69379.